Notably, in cultured primary human keratinocytes (KC), IL-17A synergizes with IL-22 and tumor necrosis factor (TNF)-α to induce the expression of IL-36, a cytokine with critical involvement in skin inflammation (27). The gene discussed is IL17A; the disease is dermatitis.